Showing results (241-250 of 312) with videos related to
Sort By:
Pageof 32
Rheumatology (Oxford, England)|November 8, 2002
Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosisP Lamprecht, J Voswinkel, T Lilienthal, et al.Advances in Experimental Medicine and Biology|January 1, 1993
ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseasesS Hauschild, W H Schmitt, E Csernok, et al.Blood|August 15, 1993
Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosisW J Mayet, E Csernok, C Szymkowiak, et al.QJM : Monthly Journal of the Association of Physicians|January 1, 1996
Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of diseaseE Reinhold-Keller, K De Groot, H Rudert, et al.Clinical and Experimental Rheumatology|January 27, 2004
ANCA against the bactericidal/permeability increasing protein (BPI-ANCA) can compromise the antibiotic function of BPI in a Wegener's granulomatosis patientH Schultz, H Heintz, G van Zandbergen, et al.Annals of the Rheumatic Diseases|November 26, 2008
Severe impaired respiratory ciliary function in Wegener granulomatosisS Ullrich, H Gustke, P Lamprecht, et al.Chest|September 3, 1998
Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activityM Reuter, A Schnabel, F Wesner, et al.Arthritis and Rheumatism|March 20, 1998
Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damageW H Schmitt, E Csernok, S Kobayashi, et al.Archives of Neurology|August 31, 2001
Standardized neurologic evaluations of 128 patients with Wegener granulomatosisK de Groot, D K Schmidt, A C Arlt, et al.Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases]A Schnabel, E Csernok, H Schultz, et al.Pageof 32